Sandoz Hrvatska company information, Employees & Contact Information

Corporate Governance Sandoz

Sandoz reaches agreement with Regeneron related to aflibercept biosimilar Drug Store News

Sandoz reaches agreement with Regeneron, resolving all patent litigation related to its US aflibercept biosimilar Sandoz

Ensuring Operational Stability Post-Spin-Off: A Conversation with Daniel Halter from Sandoz aon.com

Sandoz Family Pares Novartis Stake With $2.9 Billion Sale Bloomberg

Opportunities in the Omeprazole Market, 2025-2030: Dr. Reddy's Laboratories, Sandoz, and Perrigo Company Lead the Competition Yahoo! Finance UK

Sandoz: Jayeeta Chatterjee appointed as Head - HCM Transformation Medical Dialogues

Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France Sandoz

Sandoz and Regeneron reach agreement over biosimilar dispute Ophthalmology Times

Product Safety Notices Sandoz

Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications Sandoz

Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach Sandoz

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1] Sandoz

Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations Sandoz

Sandoz joins Energize Program to support suppliers in decarbonization efforts Sandoz

Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options Sandoz

Business Sandoz

About Sandoz Sandoz

People and culture Sandoz

Driving impact and access Sandoz

Sandoz CEO on navigating Trump's tariffs, "distorted" U.S. drug market Axios

Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars Sandoz

Sandoz signs Science Based Targets Initiative (SBTi) Commitment Letter Sandoz

Sandoz opens new Device Development Center in Cambridge, UK Sandoz

Generics Sandoz

News Archive Sandoz

Environment Sandoz

Sandoz celebrates the inauguration of new global headquarters in Basel Sandoz

Flexible-Hybrid Working at Sandoz Sandoz

Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth Fierce Pharma

Sandoz Issues Recall of One Lot of Enoxaparin Sandoz

Sandoz, on a $1.1B investment spree in Slovenia, breaks ground at new $440M biosimilar plant Fierce Pharma

Media Sandoz

FDA adds boxed warning to Teva's MS drug, Sandoz's generic FirstWord Pharma

Sandoz taps Evotec in long-term biosimilar development and manufacturing deal Fierce Pharma

Amid tough generics market, Sandoz to lay off 213 and shutter Eon Labs plant in North Carolina Fierce Pharma

In splitting from Novartis, Sandoz makes muted market debut Fierce Pharma

Evotec, Sandoz expand biosimilar production pact inked last year Fierce Pharma

Sandoz receives US FDA approval for biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation Novartis

Novartis confirms Sandoz Spin-off for October 4, 2023 Novartis

Novartis' Sandoz dips on debut after lower than expected valuation Reuters

Sandoz enters $265 million settlement agreement in U.S. price-fixing case Reuters

A ‘Greenwich Village’ on the Prairie (Published 2023) The New York Times

South Africa's Aspen expands reach with $100M buy of Sandoz's Chinese business Fierce Pharma

Years later, Eastern North Carolina plant set to close with hundreds of layoffs The Business Journals

Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine Novartis

Urwerk And The Gustave Sandoz Clock That Doesn’t Tell The Time - Reprise Quill & Pad

Sandoz at 20 years in the Philippines, named HR Asia Best Company to work for in Asia 2022 Inquirer.net

Case Note: Sandoz v. Amgen Food and Drug Law Institute (FDLI)

Prakriti Sinha joins Sandoz India as Head - People & Operations ETHRWorld.com

Bye-bye, blockbuster? AstraZeneca's Faslodex gets U.S. generic on heels of record sales year Fierce Pharma

Sandoz resumes production at Canada plant after accord reached with union Fierce Pharma

HR Giger Retrospective Comes to the Museum of Arts and Design One Year After His Death Artnet News

Sandoz India Names Prakriti Sinha As Head - People & Operations BW People

Sandoz Establishes Regional Talent Hub In Malaysia BusinessToday Malaysia

Sandoz establishes its regional talent hub in Malaysia Malaysiakini